Veterinary Medicines

Porcilis Glässer Vet Suspension for injection for pigs

Authorised
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
Download as PDF

Product identification

Medicine name:
Porcilis Glässer Vet Suspension for injection for pigs
Porcilis Glässer suspensija injekcijām cūkām
Active substance:
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
    9.10
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
    9.10
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
  • Haemophilus parasuis, serotype 5, strain 4800, Inactivated
    9.10
    enzyme-linked immunosorbent assay unit
    /
    2.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB07
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:
  • 6 x 50 ml (25 doses) in PET vials in carton (150 doses)
  • 20 ml (10 doses) in PET vials in carton
  • 100 ml (50 doses) in glass type I vials in carton
  • 12 x 100 ml (50 doses) in PET vials in carton (600 doses)
  • 12 x 100 ml (50 doses) in glass type I vials in carton (600 doses)
  • 50 ml (25 doses) in PET vials in cardboard box
  • 100 ml (50 doses) in PET vials in carton
  • 20 ml (10 doses) in glass type I vials in carton
  • 50 ml (25 doses) in glass type I vials in carton
  • 6 x 20 ml (10 doses) in PET vials in carton (60 doses)
  • 12 x 20 ml (10 doses) in PET vials in carton (120 doses)
  • 12 x 20 ml (10 doses) in glass type I vials in carton (120 doses)
  • 6 x 20 ml (10 doses) in glass type I vials in carton (60 doses)
  • 12 x 50 ml (25 doses) in PET vials in carton (300 doses)
  • 6 x 100 ml (50 doses) in glass type I vials in carton (300 doses)
  • 6 x 100 ml (50 doses) in PET vials in cardboard box (300 doses)
  • 12 x 50 ml (25 doses) in glass type I vials in cardboard box (300 doses)
  • 6 x 50 ml (25 doses) in glass type I vials in carton (150 doses)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/MRP/05/1623
Date of authorisation status change:
Reference member state:
  • Denmark
Procedure number:
  • DK/V/0107/001
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Czechia
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 28/11/2024
Download

PI.pdf

English (PDF)
Published on: 27/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."